Canada Pension Plan Investment Board’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.93M | Sell |
31,300
-160,199
| -84% | -$20.1M | ﹤0.01% | 746 |
|
2025
Q1 | $21.2M | Buy |
191,499
+157,399
| +462% | +$17.4M | 0.02% | 443 |
|
2024
Q4 | $4.65M | Sell |
34,100
-16,700
| -33% | -$2.28M | ﹤0.01% | 727 |
|
2024
Q3 | $5.85M | Sell |
50,800
-15,649
| -24% | -$1.8M | 0.01% | 671 |
|
2024
Q2 | $9.15M | Sell |
66,449
-122,100
| -65% | -$16.8M | 0.01% | 602 |
|
2024
Q1 | $26M | Buy |
188,549
+122,649
| +186% | +$16.9M | 0.03% | 403 |
|
2023
Q4 | $8.68M | Buy |
65,900
+8,800
| +15% | +$1.16M | 0.01% | 550 |
|
2023
Q3 | $6.42M | Sell |
57,100
-40,932
| -42% | -$4.6M | 0.01% | 559 |
|
2023
Q2 | $9.24M | Buy |
98,032
+17,332
| +21% | +$1.63M | 0.01% | 484 |
|
2023
Q1 | $8.17M | Buy |
80,700
+16,486
| +26% | +$1.67M | 0.01% | 492 |
|
2022
Q4 | $7.67M | Buy |
64,214
+52,514
| +449% | +$6.27M | 0.01% | 446 |
|
2022
Q3 | $1.24M | Buy |
11,700
+8,300
| +244% | +$882K | ﹤0.01% | 827 |
|
2022
Q2 | $331K | Sell |
3,400
-500
| -13% | -$48.7K | ﹤0.01% | 1013 |
|
2022
Q1 | $366K | Sell |
3,900
-21,100
| -84% | -$1.98M | ﹤0.01% | 994 |
|
2021
Q4 | $2.13M | Buy |
+25,000
| New | +$2.13M | ﹤0.01% | 881 |
|
2021
Q2 | – | Sell |
-17,855
| Closed | -$1.74M | – | 1286 |
|
2021
Q1 | $1.74M | Buy |
17,855
+10,007
| +128% | +$973K | ﹤0.01% | 896 |
|
2020
Q4 | $752K | Buy |
7,848
+6,009
| +327% | +$576K | ﹤0.01% | 1066 |
|
2020
Q3 | $177K | Sell |
1,839
-16,611
| -90% | -$1.6M | ﹤0.01% | 931 |
|
2020
Q2 | $2.25M | Sell |
18,450
-3,275
| -15% | -$400K | ﹤0.01% | 701 |
|
2020
Q1 | $1.88M | Buy |
21,725
+1,056
| +5% | +$91.4K | ﹤0.01% | 741 |
|
2019
Q4 | $2.22M | Sell |
20,669
-4,831
| -19% | -$519K | ﹤0.01% | 827 |
|
2019
Q3 | $2.3M | Sell |
25,500
-55,031
| -68% | -$4.96M | ﹤0.01% | 819 |
|
2019
Q2 | $6.8M | Buy |
+80,531
| New | +$6.8M | 0.01% | 651 |
|
2017
Q4 | – | Sell |
-19,300
| Closed | -$1.18M | – | 1205 |
|
2017
Q3 | $1.18M | Sell |
19,300
-5,400
| -22% | -$331K | ﹤0.01% | 927 |
|
2017
Q2 | $1.14M | Buy |
24,700
+8,200
| +50% | +$377K | ﹤0.01% | 911 |
|
2017
Q1 | $714K | Buy |
16,500
+4,800
| +41% | +$208K | ﹤0.01% | 946 |
|
2016
Q4 | $453K | Buy |
11,700
+2,400
| +26% | +$92.9K | ﹤0.01% | 865 |
|
2016
Q3 | $471K | Buy |
+9,300
| New | +$471K | ﹤0.01% | 877 |
|
2016
Q2 | – | Sell |
-17,625
| Closed | -$697K | – | 1132 |
|
2016
Q1 | $697K | Sell |
17,625
-50,800
| -74% | -$2.01M | ﹤0.01% | 867 |
|
2015
Q4 | $3.87M | Buy |
68,425
+11,400
| +20% | +$645K | 0.02% | 586 |
|
2015
Q3 | $2.27M | Buy |
+57,025
| New | +$2.27M | 0.01% | 724 |
|